4.7 Article

Protein assisted one pot controlled synthesis of monodispersed and multifunctional colloidal silver gold alloy nanoparticles

Journal

JOURNAL OF MOLECULAR LIQUIDS
Volume 291, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.molliq.2019.111303

Keywords

Biogenic synthesis; Silver gold alloy nanoparticles; Anti-cancer activity; Curcumin delivery; Bioavailability

Funding

  1. Science and Engineering Research Board, Government of India [SERB/F/4290/2016-17]
  2. National Institute of Technology

Ask authors/readers for more resources

Here, we prepared gold silver alloy nanoparticle (AgAuNPcs) of similar to 8.5 nm mean size via one-pot biogenic synthesis using casein as reducing as well as capping agent and explored its potential in various biomedical applications using curcumin (CUR) as a drug delivery agent. When we prepared the nanoconjugate with curcumin (AgAuNPCS-CUR) of 10.5 nm mean size via chemical activation followed by loading, it demonstrated excellent curcumin loading capacity (221.19 mg/g). Furthermore, AgAuNPCS-CUR exhibited pH driven CUR release up to a maximum of 85% at a pH 6.0. We also observed its significant storage stability up to 30 days at 4 degrees C. When applied in cancer cells, the nanoconjugate demonstrated higher cytotoxicity to multiple cancer cells (MCF-7, MDAMB231, HeLa and MG 63) than free CUR. However, such cytotoxicity was further enhanced by nearly similar to 8-10% using the folate receptor (FR)-based targeting. Furthermore, it demonstrated excellent antioxidant, as well as anti-inflammatory activity (NO assay) and such activity was found higher than that of free CUR. Both AgAuNPcs and AgAuNPCS-CUR also exhibited excellent cytocompatibility to human keratinocyte and erythrocyte cells. Hence, from the overall findings, we concluded that our biogenically synthesized AgAuNPCS alloy nanoparticle has, anti-inflammatory, anti-bacterial, anti-oxidant activity as well as potential for targeted therapy (in cancer) via controlled CUR delivery in biomedical applications. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available